Robert Crayhon

The NY Times reports on how drugs are overused in dementia patients.  How about the bigger story–that there are no drugs that make any substantial difference in dementia, not a one, and yet we have PhosphatidylSerine, Acetyl-L-Carnitine, and GlyceroPhosphoCholine, three nutrients which have been found helpful in restoring the function of the senile brain, according to research in over 5,000 older adults. At a conference where I was lecturing, an attendee said that neurologists in her city didn’t like GlyceroPhosphoCholine. I said that’s like firemen not liking water–it’s irrelevant. It works, and it should be the front line therapy.Perhaps what is needed is a class-action lawsuit from dementia patients and their families to demand a higher standard of orthomolecular care. Not using therapeutic micronutrition with the aforementioned nutrients in light of available data should now be considered malpractice.